EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
24 11-2022

Save the date for the launch event of the RETHINKING Alzheimer’s disease White Paper!

2022-11-24T08:49:52+00:0024-11-2022|News|

The launch event of the RETHINKING Alzheimer's disease White Paper, calling for change in Alzheimer's care, will take place virtually on 24 January 2023 at 12:30 - 14:00. About Alzheimer's disease Alzheimer’s disease (AD) is a neurodegenerative disease that progresses in stages, beginning with a long silent phase before symptoms occur. It is the underlying cause [...]

26 10-2022

Alzheimer Europe Conference: Symposium on rethinking the early detection and diagnosis of Alzheimer’s disease

2022-10-27T09:41:23+00:0026-10-2022|News|

Alzheimer’s disease (AD) is a major unmet medical need that requires innovation to be aligned with public health needs. It represents between 60% and 70% of the dementia cases. It is still diagnosed too late when the symptoms become evident as the disease progresses.  AD is now portrayed as continuum consisting of 3 stages: [...]

5 07-2021

EBC supports the need to prioritise the rapidly growing challenge of Alzheimer’s disease

2021-07-07T11:46:51+00:0005-07-2021|News|

Alzheimer’s disease (AD) is a neurodegenerative disease that progresses in stages, beginning with a long silent phase before symptoms occur, and the underlying cause in 70% of people with dementia. Dementia, which is not a specific disease but an overall term that describes a group of symptoms, is characterized by a decline in memory, thinking, [...]

3 10-2019

“Time matters: A call to prioritize brain health” report launches

2019-10-03T10:00:16+00:0003-10-2019|News|

Experts call for coordinated public education and research programmes to avert a brain disease crisis   Experts are calling for a public health campaign aimed at promoting a ‘brain-healthy lifestyle’ to reduce the risk of developing neurodegenerative brain diseases, such as Alzheimer’s disease and Parkinson’s disease. The campaign should support existing health promotion work by [...]

3 04-2019

EBC-endorsed “Alzheimer’s Policy toolkit for Members of the European Parliament” released

2019-04-03T08:12:29+00:0003-04-2019|News|

Alzheimer’s disease (AD) – the most common cause of dementia – is one of the most significant medical and societal challenges of our time. It does not discriminate and affects everyone, across all generations – from the people who develop the condition, to the families that care for them and the taxpayers who fund health [...]

21 11-2018

Launch of “Driving policy to optimise care for people with Alzheimer’s Disease in Europe today and tomorrow” white paper

2018-11-21T23:07:41+00:0021-11-2018|News|

EBC endorses joint Alzheimer’s white paper setting out strategic vision on policy action to deliver better care for people with Alzheimer’s, their families and their carers in Europe The white paper,  Driving policy to optimise care for people with Alzheimer’s disease in Europe today and tomorrow, launched today in the European Parliament, outlines clear priorities for [...]

4 10-2018

Event Report: “The Socioeconomic impact of Alzheimer’s in Europe”

2018-10-04T13:05:02+00:0004-10-2018|News|

On the 25th of September, EBC held its latest event in the European Parliament, this time building on the Value of Treatment's work on Alzheimer's and The Socioeconomic impact of Alzheimer’s in Europe. This event was an opportunity to further present the EBC Value of Treatment project, particularly the work and findings of the Alzheimer's [...]

3 10-2017

EBC at 27th Alzheimer Europe Conference

2017-10-03T12:03:42+00:0003-10-2017|News|

EBC is in Berlin this week for the 27th Alzheimer Europe Conference, focusing this year on the theme "care today, cure tomorrow". In partnership with MSD we are present at the exhibition and will hold a special symposium on the 4th October during lunch (beginning 12:45): Early intervention in Alzheimer’s disease: For a new understanding of [...]

Go to Top